SYNMF (Synthetic MR AB) ROC (Joel Greenblatt) %: -978.91% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SYNMF Synthetic MR AB SYNMF
63 GF Score
Price $0.19
GF Value $1.41
! 3 Warning Signs
View Full Analysis

What is Synthetic MR AB ROC (Joel Greenblatt) %?

Synthetic MR AB SYNMF 63 ROC (Joel Greenblatt) % is -978.91% as of Mar. 2026. GuruFocus rates SYNMF with a GF Score™ of 63/100 and a GF Value™ of $1.41. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Synthetic MR AB ranks worse than 91.92% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Synthetic MR AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -978.91%.

The historical rank and industry rank for Synthetic MR AB's ROC (Joel Greenblatt) % or its related term are showing as below:

SYNMF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1566.69   Med: 425.75   Max: 1190.09
Current: -1566.69

During the past 13 years, Synthetic MR AB's highest ROC (Joel Greenblatt) % was 1190.09%. The lowest was -1566.69%. And the median was 425.75%.

SYNMF's ROC (Joel Greenblatt) % is ranked worse than
91.92% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 12.47 vs SYNMF: -1566.69

Synthetic MR AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Synthetic MR AB  (OTCPK:SYNMF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Synthetic MR AB ROC (Joel Greenblatt) % Related Terms


Synthetic MR AB ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Synthetic MR AB's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synthetic MR AB ROC (Joel Greenblatt) % Chart

Synthetic MR AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,115.53 490.10 454.71 -429.46 -1,716.37

Synthetic MR AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,139.63 -1,087.95 -3,418.18 -751.63 -978.91

SYNMF vs VEEV, BTSG, TEM: ROC (Joel Greenblatt) % Comparison

For the Health Information Services subindustry, Synthetic MR AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's ROC (Joel Greenblatt) % falls into.


SYNMF
63GF Score
Synthetic MR AB SYNMF
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synthetic MR AB ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.582 + 0 + 0.085) - (0.387 + 0 + 2.539)
=-1.259

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.144 + 0 + 0) - (0.317 + 0 + 2.608)
=-0.781

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Synthetic MR AB for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2.692/( ( (0.312 + max(-1.259, 0)) + (0.238 + max(-0.781, 0)) )/ 2 )
=-2.692/( ( 0.312 + 0.238 )/ 2 )
=-2.692/0.275
=-978.91 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -978.91% mean?
Synthetic MR AB (SYNMF) has a ROC (Joel Greenblatt) % of -978.91% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Synthetic MR AB and its competitors. According to the industry distribution chart, Synthetic MR AB ranks #614 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 91.9%.
Is Synthetic MR AB's ROC (Joel Greenblatt) % too high?
Synthetic MR AB's current ROC (Joel Greenblatt) % is -978.91%. Based on the distribution chart, Synthetic MR AB ranks #614 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Synthetic MR AB has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's ROC (Joel Greenblatt) % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Synthetic MR AB ranks #614 out of 668 companies for ROC (Joel Greenblatt) %. This places Synthetic MR AB in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 12.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.47, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Synthetic MR AB and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synthetic MR AB's current ROC (Joel Greenblatt) % is -978.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Synthetic MR AB (SYNMF) has a current ROC (Joel Greenblatt) % of -978.91%. The stock's GF Value™ is $1.41, compared to a current price of $0.19 — trading 86.8% below its estimated fair value. The current ROC (Joel Greenblatt) % is -978.91%. Synthetic MR AB's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Synthetic MR AB (SYNMF), the current ROC (Joel Greenblatt) % is -978.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synthetic MR AB (SYNMF) Overvalued in 2026?

Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued. The current stock price of $0.19 is trading 86.8% below its estimated GF Value™ of $1.41.

Key valuation signals for SYNMF:

  • ROC (Joel Greenblatt) %: -978.91%
  • GF Value™: $1.41 vs. price of $0.19 (86.8% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the SYNMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synthetic MR AB Business Description

Other Exchanges SYNT:Sweden9480:Germany
Address Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
63GF Score

Get the complete analysis for SYNMF

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.19
Price
$1.41
GF Value